Decreased expression of the DBC2 gene and its clinicopathological significance in breast cancer: correlation with aberrant DNA methylation

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biotechnology Letters

• Publication date

  2013-04-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10529-013-1190-xPMID 23546941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of CHD5 in human cancers: 10 years later.

  2014cited by this paper
• Epigenetic silencing of CHD5, a novel tumor‐suppressor gene, occurs in early colorectal cancer stages

  2014cited by this paper
• Prognostic Value of Breast Cancer Subtypes, Ki‐67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women

  2013cited by this paper
• Breast Cancer Statistics

  2013cited by this paper
• Epigenetic changes during cell transformation.

  2013cited by this paper
• Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases

  2012cited by this paper
• Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer

  2012cited by this paper
• CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.

  2012cited by this paper
• Mechanisms of CHD5 Inactivation in Neuroblastomas

  2012cited by this paper
• RhoBTB2 (DBC2) functions as tumor suppressor via inhibiting proliferation, preventing colony formation and inducing apoptosis in breast cancer cells.

  2011cited by this paper
• Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells

  2010cited by this paper
• A novel tumor suppressor gene RhoBTB2 (DBC2): Frequent loss of expression in sporadic breast cancer

  2010cited by this paper
• CHD5 is down-regulated through promoter hypermethylation in gastric cancer

  2009cited by this paper
• Distinct High-Profile Methylated Genes in Colorectal Cancer

  2009cited by this paper
• The quest for the 1p36 tumor suppressor.

  2008cited by this paper
• DBC2 gene is silenced by promoter methylation in bladder cancer.

  2008cited by this paper
• CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas

  2008cited by this paper
• Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer.

  2008cited by this paper
• Chromatin remodeling factor CHD5 is silenced by promoter CpG island hypermethylation in human cancer

  2008influential reference
• Genetic and epigenetic alterations in breast cancer: what are the perspectives for clinical practice?

  2008cited by this paper
• CHD5 is a tumor suppressor at human 1p36.

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• Rethinking TNM: breast cancer TNM classification for treatment decision-making and research.

  2006cited by this paper
• Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.

  2006cited by this paper
• DBC2 significantly influences cell-cycle, apoptosis, cytoskeleton and membrane-trafficking pathways.

  2005cited by this paper
• [DNA methylation and cancer].

  2005cited by this paper
• Expression analysis of candidate breast tumour suppressor genes on chromosome 16q

  2005cited by this paper
• DNA methylation and cancer.

  2004cited by this paper
• Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.

  2003cited by this paper
• DBC2, a candidate for a tumor suppressor gene involved in breast cancer

  2002cited by this paper
• DNA methylation and gene silencing in cancer: which is the guilty party?

  2002cited by this paper
• Expert Commentary.

  2002cited by this paper
• Role of DNA Methylation and Histone Acetylation in Steroid Receptor Expression in Breast Cancer

  2001cited by this paper
• Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.

  2000cited by this paper
• Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

  2000cited by this paper
• Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.

  1995cited by this paper
• Two distinct regions involved in 1p deletion in human primary breast cancer.

  1993cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• The inheritance of epigenetic defects.

  1987cited by this paper
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

  1987cited by this paper

• Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor

  2024cites this paper
• Current data and future perspectives on DNA methylation in ovarian cancer (Review)

  2024cites this paper
• Effect of smoking on methylation and semen parameters

  2024cites this paper
• BTB protein family and human breast cancer: signaling pathways and clinical progress

  2023cites this paper
• The peritumoral brain zone in glioblastoma: where we are and where we are going

  2022cites this paper
• Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2

  2021cites this paper
• Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview

  2021cites this paper
• Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview

  2021cites this paper
• The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses

  2020cites this paper
• The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B

  2017cites this paper
• Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis

  2016cites this paper
• DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer

  2016cites this paper
• Hsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex

  2014cites this paper
• RHOBTB2 (Rho-related BTB domain containing 2)

  2011influential citation